Publication
Efficacy and Safety of First-Line Chemotherapy With Gemcitabine Plus Nab-Paclitaxel in Unresectable Gallbladder Cancer.
Yue Yang, Ziyou Wu, Yidi Zhu, Yu Zhang, Zhe Zhou, Xiaoling Song, Ziyi Yang, Shilei Liu, Runfa Bao, Xuefeng Wang, Xiangsong Wu, Wei Gong
- Source
- PubMed
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260929-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
PURPOSE: The purpose of this study is to evaluate the efficacy and safety of nab-paclitaxel combined with gemcitabine (AG regimen) as a first-line chemotherapy for patients with unresectable gallbladder cancer (GBC). MATERIALS AND METHODS: A retrospective analysis was conducted on patients…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Gallbladder Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available